EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature

Benjamin C Billingsley iD, Ritica Chaudhary, Michael W Morris, Jennifer A Cox, Sandra M Camacho-Gomez, Neha Varshney iD

International Journal of Surgical Pathology · 2025

DOI: 10.1177/10668969241246470 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2025. Verfasst von Benjamin C Billingsley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Stomach Neoplasms, Protein Kinase Inhibitors, Crizotinib. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm of borderline malignant potential. Nearly half of all IMTs have rearrangement of anaplastic lymphoma kinase (ALK) locus on chromosome 2p23 which can be treated with targeted therapy. Herein, we describe an unusual presentation of IMT involving an anatomical region rarely implicated in this disease process. A 15-year-old male patient came to the ER with dysphagia and coffee ground emesis. On esophagogastroscopy, a nodular luminal obstructing 30 × 50 mm mass in the lower esophagus was found, which was continuous with a large, partially circumferential gastric mass extending from the mid-body to the proximal antrum. Biopsies from esophageal and gastric masses revealed submucosal lesions composed of cytologically bland spindle and epithelioid cells, intermingled with inflammatory infiltrate, for which several immunohistochemical (IHC) stains were performed. The molecular study demonstrated ATIC::ALK fusion. Based on morphological, IHC, and molecular study findings, the diagnosis of ALK-positive IMT was rendered. Because surgical excision was deemed infeasible, the patient was started on ALK-inhibiting therapy with crizotinib. The patient responded well with no evidence of residual or recurrent disease on follow-up imaging or surveillance esophagogastroduodenoscopy. Crizotinib was ultimately discontinued after 10 months of therapy, and the patient continues to undergo surveillance imaging for monitoring of disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseStomach NeoplasmsProtein Kinase InhibitorsCrizotinibNeoplasms, Muscle TissueEsophageal NeoplasmsHumansMaleAdolescentEsophagusTreatment OutcomeStomach

Stichwörter der Autor:innen

ALKGI bleedIMTanaplastic lymphoma kinasecrizotinibgastroesophageal junctioninflammatory myofibroblastic tumorinflammatory pseudotumorpediatricstomach

Substanzen

Anaplastic Lymphoma KinaseALK protein, humanProtein Kinase InhibitorsCrizotinib

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Division of Pediatric, Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
  • Division of Hematology and Oncology, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Texas at Austin, Austin, TX, USA.

ORCID-Profile: Benjamin C Billingsley, Neha Varshney

Zitieren

APA

Billingsley, B. C., Chaudhary, R., Morris, M. W., Cox, J. A., Camacho-Gomez, S. M., & Varshney, N. (2025). Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969241246470

Vancouver

Billingsley BC, Chaudhary R, Morris MW, Cox JA, Camacho-Gomez SM, Varshney N. Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature. International Journal of Surgical Pathology. 2025. doi:10.1177/10668969241246470

BibTeX
@article{Billingsley2025,
  author = {Billingsley, Benjamin C and Chaudhary, Ritica and Morris, Michael W and Cox, Jennifer A and Camacho-Gomez, Sandra M and Varshney, Neha},
  title = {Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature},
  journal = {International Journal of Surgical Pathology},
  year = {2025},
  doi = {10.1177/10668969241246470}
}
Kostenlos starten →